Pay in 4 interest-free payments of $6.50 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
The addition of the AHK-Cu complex may potentially have stimulated the proliferation of normal dermal fibroblasts and possibly enhanced their viability
Key Benefits Observed in Clinical Trials Treatment of Erythropoietic Protoporphyria (EPP): MT-1 (Afamelanotide) is FDA-approved for use in patients with EPP, a rare genetic disorder that causes extreme photosensitivity, leading to severe pain and skin damage upon light exposure
Ready to get started, or have questions about your current program
Discuss labs and protocols with a clinician if you have medical conditions or take medications
Prioprietary Blend 934 Mgyerba Mate (Leaf) Extract, Guarana (Seed) Extract, Coffee (Bean) Extract, Damiana (Leaf) Extract, Cacao (Seed) Extract, Brown Rice (Seed) Powder, Cayenne (Fruit) Powder, Chlorella (Algae) Powder, Grape (Seed) Extract, Blueberry (Fruit) Powder, Cranberry (Fruit) Powder, Sour Cherry (Fruit) Powder, Plum (Fruit) Powder, Raspberry (Fruit And Seed) Concentrate, Strawberry (Fruit) Powder, Bilberry (Fruit) Powder, Grape (Fruit) Powder, Bilberry (Fruit) Extract, Blueberry (Fruit) Extract
To enhance the therapeutic potential of the ruthenium catalyst and tackle challenging hypoxic tumors, the metal complexes is covalently linked to the side chain of a polymer that contains a carbon fluorinated moiety capable of delivering oxygen to the tumor site
